SG Americas Securities, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 86 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,258
-51.4%
276,393
-24.8%
0.01%
-30.0%
Q2 2023$2,587
-99.7%
367,467
+350.6%
0.02%
+100.0%
Q2 2022$900,000
-76.6%
81,549
-64.7%
0.01%
-64.3%
Q1 2022$3,847,000
+3495.3%
231,077
+4008.0%
0.03%
+2700.0%
Q4 2021$107,000
-76.8%
5,625
-70.0%
0.00%
-50.0%
Q3 2021$462,000
-21.7%
18,728
-17.4%
0.00%
-33.3%
Q2 2021$590,000
-19.0%
22,671
-1.4%
0.00%
-25.0%
Q1 2021$728,000
+108.6%
22,989
+205.3%
0.00%
+100.0%
Q4 2020$349,000
-70.6%
7,531
-79.2%
0.00%
-75.0%
Q3 2020$1,189,000
+560.6%
36,133
+449.7%
0.01%
+700.0%
Q2 2020$180,000
-77.9%
6,573
-75.8%
0.00%
-87.5%
Q1 2020$814,000
+36.6%
27,206
+26.4%
0.01%
+60.0%
Q4 2019$596,000
+66.5%
21,516
+9.3%
0.01%
+66.7%
Q3 2019$358,000
-89.2%
19,691
-85.4%
0.00%
-87.0%
Q2 2019$3,313,000
+402.7%
135,101
+95.0%
0.02%
+283.3%
Q1 2019$659,000
+266.1%
69,269
+241.2%
0.01%
+200.0%
Q4 2018$180,000
+53.8%
20,301
+122.7%
0.00%
+100.0%
Q2 2018$117,000
-45.8%
9,116
-28.6%
0.00%
-50.0%
Q1 2018$216,000
-44.6%
12,776
-74.6%
0.00%
-33.3%
Q3 2017$390,000
+413.2%
50,295
+385.3%
0.00%
+200.0%
Q2 2017$76,00010,3640.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
MHR Fund Management 11,997,103$84,459,60511.88%
MPM BioImpact LLC 2,950,118$20,768,8314.18%
Perceptive Advisors 14,036,410$98,816,3262.86%
Velan Capital Investment Management LP 240,000$1,689,6001.57%
Parametrica Management Ltd 96,500$679,3601.31%
Boxer Capital, LLC 3,705,133$26,0841.21%
Soleus Capital Management, L.P. 1,239,777$8,728,0300.97%
Opaleye Management Inc. 421,000$2,963,8400.71%
683 Capital Management, LLC 1,400,000$9,856,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 1,758,759$12,381,6650.70%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders